• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例罕见的食管旁及膈肌转移的SDHA缺陷型胃肠道间质瘤(GIST)病例报告。

An unusual paraesophageal and diaphragmatic SDHA-deficient gastrointestinal stromal tumor (GIST) metastases case report.

作者信息

Teke Martha E, Choi Agnes, Sarvestani Amber Leila, Blakely Andrew M, Carr Shamus R

机构信息

Surgical Oncology Program, NCI, NIH, Bethesda, MD, USA.

Thoracic Surgical Oncology Branch, NCI, NIH, Bethesda, MD, USA.

出版信息

J Gastrointest Oncol. 2023 Feb 28;14(1):429-434. doi: 10.21037/jgo-22-714. Epub 2023 Feb 20.

DOI:10.21037/jgo-22-714
PMID:36915446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10007948/
Abstract

BACKGROUND

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract and have diverse tumor biology. Succinate dehydrogenase ()-deficient GIST, comprise less than 10% of all GIST, with mutational loss of the catalytic subunit being the most common subtype. Contrary to typical GISTs harboring inactivating mutations in -deficient GIST has varying biology and behavior, occurring at a younger age, often metastatic on presentation and frequently refractory to conventional tyrosine kinase inhibitors (TKI). Liver and peritoneum are their most common sites of metastases, and extra-abdominal spread to the diaphragm or mediastinum has not been previously described.

CASE DESCRIPTION

Herein, we present a case of a 44-year-old female patient with a history of -deficient GISTs with multiple previous metastasectomies who presented with recurrence to the paraesophageal region and diaphragm which was identified upon routine positron emission tomography (PET) surveillance. Patient subsequently underwent a robotic assisted metastasectomy using a thoracic approach. Follow up was obtained 2 months following procedure and there was no evidence of recurrence.

CONCLUSIONS

-deficient GISTs have unique tumor biology and management of metastatic lesions remains an area of debate and discovery. Overall, this report highlights the need for comprehensive knowledge of the disease, a skilled surgical team, and multi-disciplinary involvement in order to optimize care and ensure favorable outcomes in this patient population.

摘要

背景

胃肠道间质瘤(GIST)是胃肠道最常见的间充质肿瘤,具有多样的肿瘤生物学特性。琥珀酸脱氢酶(SDH)缺陷型GIST占所有GIST的比例不到10%,催化亚基的突变缺失是最常见的亚型。与典型的GIST不同,典型GIST存在失活突变,而SDH缺陷型GIST具有不同的生物学特性和行为,发病年龄较轻,就诊时往往已发生转移,且通常对传统酪氨酸激酶抑制剂(TKI)耐药。肝脏和腹膜是其最常见的转移部位,此前尚未有过向膈肌或纵隔的腹外转移报道。

病例描述

在此,我们报告一例44岁女性患者,有SDH缺陷型GIST病史,此前曾多次进行转移灶切除术,此次因食管旁区域和膈肌复发就诊,通过常规正电子发射断层扫描(PET)监测得以确诊。患者随后接受了胸腔入路的机器人辅助转移灶切除术。术后2个月进行随访,未发现复发迹象。

结论

SDH缺陷型GIST具有独特的肿瘤生物学特性,转移性病变的管理仍是一个存在争议和有待探索的领域。总体而言,本报告强调了全面了解该疾病、具备专业手术团队以及多学科参与的必要性,以便优化治疗并确保该患者群体获得良好预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/10007948/528953525aa9/jgo-14-01-429-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/10007948/334b0d5bb765/jgo-14-01-429-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/10007948/1c887c083c94/jgo-14-01-429-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/10007948/528953525aa9/jgo-14-01-429-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/10007948/334b0d5bb765/jgo-14-01-429-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/10007948/1c887c083c94/jgo-14-01-429-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911e/10007948/528953525aa9/jgo-14-01-429-f3.jpg

相似文献

1
An unusual paraesophageal and diaphragmatic SDHA-deficient gastrointestinal stromal tumor (GIST) metastases case report.一例罕见的食管旁及膈肌转移的SDHA缺陷型胃肠道间质瘤(GIST)病例报告。
J Gastrointest Oncol. 2023 Feb 28;14(1):429-434. doi: 10.21037/jgo-22-714. Epub 2023 Feb 20.
2
Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.琥珀酸脱氢酶缺陷型胃肠道间质瘤(GISTs)——综述
Int J Biochem Cell Biol. 2014 Aug;53:514-9. doi: 10.1016/j.biocel.2014.05.033. Epub 2014 Jun 2.
3
Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors.SDHA 表达缺失可鉴定琥珀酸脱氢酶缺陷型胃肠道间质瘤中的 SDHA 突变。
Am J Surg Pathol. 2013 Feb;37(2):226-33. doi: 10.1097/PAS.0b013e3182671155.
4
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.KIT/PDGFRA 野生型胃肠道间质瘤的分子亚型:来自美国国立卫生研究院胃肠道间质瘤临床中心的报告。
JAMA Oncol. 2016 Jul 1;2(7):922-8. doi: 10.1001/jamaoncol.2016.0256.
5
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.KIT/PDGFRA野生型胃肠道间质瘤中琥珀酸脱氢酶复合物所有亚基SDHA、SDHB、SDHC、SDHD的分析
Eur J Hum Genet. 2014 Jan;22(1):32-9. doi: 10.1038/ejhg.2013.80. Epub 2013 Apr 24.
6
A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation.一名携带种系SDHB突变患者的十二指肠琥珀酸脱氢酶缺陷型胃肠道间质瘤
J Clin Endocrinol Metab. 2017 May 1;102(5):1447-1450. doi: 10.1210/jc.2017-00165.
7
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations.携带 SDHA 突变的转移性 SDH 缺陷型胃肠道间质瘤具有良好的生存结局。
Genet Med. 2015 May;17(5):391-5. doi: 10.1038/gim.2014.115. Epub 2014 Sep 4.
8
SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors.SDHA 功能丧失突变存在于一部分年轻的野生型胃肠道间质瘤中。
BMC Cancer. 2012 Sep 14;12:408. doi: 10.1186/1471-2407-12-408.
9
Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.血小板衍生生长因子受体A(PDGFRA)突变的胃肠道间质瘤中的琥珀酸脱氢酶缺乏症
BMC Cancer. 2017 Aug 2;17(1):512. doi: 10.1186/s12885-017-3499-7.
10
[Expression of succinate dehydrogenase subunit protein in succinate dehydrogenase-deficient gastrointestinal stromal tumors].[琥珀酸脱氢酶缺乏型胃肠道间质瘤中琥珀酸脱氢酶亚基蛋白的表达]
Zhonghua Bing Li Xue Za Zhi. 2018 Apr 8;47(4):252-257. doi: 10.3760/cma.j.issn.0529-5807.2018.04.005.

引用本文的文献

1
Transcatheter arterial chemoembolization with tyrosine kinase inhibitor in the 12-year treatment of hepatic metastases from gastrointestinal stromal tumor: a case report.经导管动脉化疗栓塞联合酪氨酸激酶抑制剂治疗胃肠道间质瘤肝转移12年:病例报告
J Gastrointest Oncol. 2024 Jun 30;15(3):1315-1323. doi: 10.21037/jgo-24-403. Epub 2024 Jun 27.

本文引用的文献

1
Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response.建立患者来源的琥珀酸脱氢酶缺陷型胃肠道间质瘤模型以预测治疗反应。
Clin Cancer Res. 2022 Jan 1;28(1):187-200. doi: 10.1158/1078-0432.CCR-21-2092. Epub 2021 Aug 23.
2
Cytoreductive Surgery may be beneficial for highly selected patients with Metastatic Gastrointestinal Stromal Tumors receiving Regorafenib facing Local Progression: A Case Controlled Study.减瘤手术可能对高度选择的接受瑞戈非尼治疗且面临局部进展的转移性胃肠道间质瘤患者有益:一项病例对照研究。
J Cancer. 2021 Apr 12;12(11):3335-3343. doi: 10.7150/jca.50324. eCollection 2021.
3
Trends and Predictors of Failure of Minimally Invasive Surgery for Gastric GIST.
胃间质瘤微创手术失败的趋势及预测因素
J Gastrointest Surg. 2021 May;25(5):1319-1322. doi: 10.1007/s11605-020-04816-y. Epub 2020 Oct 15.
4
Current management of succinate dehydrogenase-deficient gastrointestinal stromal tumors.琥珀酸脱氢酶缺陷型胃肠道间质瘤的当前治疗策略。
Cancer Metastasis Rev. 2019 Sep;38(3):525-535. doi: 10.1007/s10555-019-09818-0.
5
Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors.琥珀酸脱氢酶缺陷型胃肠道间质瘤。
Arch Pathol Lab Med. 2020 May;144(5):655-660. doi: 10.5858/arpa.2018-0370-RS. Epub 2019 Jun 6.
6
Metastatic pattern and prognosis of gastrointestinal stromal tumor (GIST): a SEER-based analysis.基于 SEER 分析的胃肠道间质瘤(GIST)转移模式和预后。
Clin Transl Oncol. 2019 Dec;21(12):1654-1662. doi: 10.1007/s12094-019-02094-y. Epub 2019 Mar 23.
7
Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study.转移性胃肠间质瘤的细胞减灭手术联合舒尼替尼治疗对比联合伊马替尼治疗:一项多中心队列研究。
Eur J Surg Oncol. 2019 Mar;45(3):318-323. doi: 10.1016/j.ejso.2018.08.001. Epub 2018 Aug 11.
8
Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis.酪氨酸激酶抑制剂治疗转移性胃肠道间质瘤的细胞减灭术:2 家机构的分析。
Ann Surg. 2018 Aug;268(2):296-302. doi: 10.1097/SLA.0000000000002281.
9
Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic.野生型胃肠道间质瘤的外科治疗:来自美国国立卫生研究院儿科与野生型胃肠道间质瘤诊所的报告
J Clin Oncol. 2017 Feb 10;35(5):523-528. doi: 10.1200/JCO.2016.68.6733. Epub 2016 Dec 28.
10
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy.瑞戈非尼用于标准酪氨酸激酶抑制剂治疗失败后的转移性和/或不可切除胃肠道间质瘤患者的多中心II期试验的长期随访结果
Ann Oncol. 2016 Sep;27(9):1794-9. doi: 10.1093/annonc/mdw228. Epub 2016 Jul 1.